Join the India Equity Telegram Group for analysis, updates and results

GUFICBIO has declared results for the period ended Sep 2021.

Quarterly Results

[s2If !current_user_can(access_s2member_level1)] Register and Login below to read result analysis [lwa][/s2If] [s2If current_user_can(access_s2member_level1)]

• Sales for period ended Sep 2021 is Rs 194.0 cr compared to Rs 128.0 cr for period ended Sep 2020, a rise of 51.6%
• Operating Profits reported at Rs 36.0 cr for period ended Sep 2021 vis-vis 29.0 for period ended Sep 2020 .
• Operating Margins contracted -410.0 bps for period ended Sep 2021 vis-vis Sep 2020 .
• The EPS for Sep 2021 was Rs 2.41 compared to Rs 3.22 for previous quarter ended Jun 2021 and Rs 2.23 for Sep 2020
• The stock is trading at Rs 194 and a market cap of Rs 1872 cr

[/s2If]

Trading Chart

Further analysis and Full Company Research with investing scores is available here: GUFICBIO

Join BharatEquity Telegram Channel for updated India results, analysis and News
Join Our Twitter